In this episode of the Arbitration Conversation, Amy interviews Allen Waxman, the President & CEO of the International Institute for Conflict Prevention and Resolution (CPR).
Prior to joining CPR, Mr. Waxman served as General Counsel of Pfizer, at Eisai Inc – the North American affiliate of the Japanese-based pharmaceutical company, Eisai Co Ltd – where he also led the Market Access business unit, and at Roivant Sciences, a start-up building biotech and healthcare technology companies. He also practiced law as a partner at Williams & Connolly, in Washington, D.C.
This article first appeared on Urbas Arbitral, here. Distinguishing between actions involving personal and real rights, Mr. Justice Martin Castonguay in Specter Aviation v. Laprade, 2020 QCCS 4392 held that article 3148...
By Daniel UrbasIn this round of Arbitration Tips-N-Tools (TNT), Professor Amy Schmitz asks some of the leading arbitration practitioners about planning and executing a preliminary arbitration hearing, especially in a digital world...
By Daniel Urbas, George Friedman, DeAndra Roaché, Theo Cheng, Amy SchmitzIn this episode of the Arbitration Conversation, Amy interviews Prof. Imre Szalai of Loyola University New Orleans, a nationally-known scholar regarding the Federal Arbitration Act, and his teaching interests and...
By Imre Szalai, Amy Schmitz
With the purchase of a Featured Membership, you will be shown on the front page of Arbitrate.com to web site visitors from your city and region (“state” if you are in the USA). You may appear in more than one city/region by purchasing additional locations.
